Haemonetics
313 hedge funds and large institutions have $3.41B invested in Haemonetics in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 126 increasing their positions, 102 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5.77% less ownership
Funds ownership: 112.62% → 106.86% (-5.8%)
23% less capital invested
Capital invested by funds: $4.42B → $3.41B (-$1.01B)
Holders
313
Holding in Top 10
4
Calls
$26M
Puts
$20.1M
Top Buyers
| 1 | +$94.9M | |
| 2 | +$28.6M | |
| 3 | +$25.1M | |
| 4 |
Citigroup
New York
|
+$19.8M |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$17.6M |
Top Sellers
| 1 | -$181M | |
| 2 | -$89.5M | |
| 3 | -$85.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$62.9M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$24.4M |